Coronary Artery Disease - Nursing Case Study

Pathophysiology

• Primary mechanism: Atherosclerosis - The buildup of cholesterol-rich plaques in coronary arteries narrows the vessel lumen, reducing blood flow to the heart muscle. This process is initiated by endothelial injury, which promotes lipid accumulation and inflammatory cell infiltration.

• Secondary mechanism: Endothelial dysfunction - Damage to the endothelial lining of coronary arteries disrupts its ability to regulate blood flow and maintain vascular homeostasis. This dysfunction enhances vasoconstriction and promotes further plaque formation, exacerbating ischemic conditions.

• Key complication: Myocardial ischemia - Reduced blood supply from narrowed arteries leads to insufficient oxygen delivery to the heart muscle, potentially causing chest pain (angina) and, if prolonged or severe, can result in myocardial infarction (heart attack).

Patient Profile

Demographics:

58-year-old male, construction worker

History:

• Key past medical history: Hypertension, hyperlipidemia, type 2 diabetes

• Current medications: Atorvastatin, Metformin, Lisinopril, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain and shortness of breath

• Key symptoms: Fatigue, intermittent chest discomfort, occasional dizziness

• Vital signs: Blood pressure 150/95 mmHg, heart rate 102 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, oxygen saturation 92% on room air

Section 1

As the patient continues to be assessed in the emergency department, his condition evolves, revealing new complications. An electrocardiogram (ECG) shows ST-segment depression in the anterior leads, indicating ongoing myocardial ischemia. Laboratory investigations show elevated cardiac biomarkers, with troponin levels rising to 0.35 ng/mL (normal <0.04 ng/mL), suggesting myocardial injury. Additionally, his blood glucose is noted to be 240 mg/dL, indicating poorly controlled diabetes, which could be contributing to endothelial dysfunction and exacerbating his coronary artery disease. The patient's blood lipid panel reveals elevated LDL cholesterol at 160 mg/dL, further confirming the significant role of hyperlipidemia in his atherosclerotic process.

Despite initial administration of sublingual nitroglycerin, the patient's chest discomfort persists, accompanied by increased diaphoresis and anxiety. His blood pressure remains elevated at 160/100 mmHg, and oxygen saturation has worsened slightly to 90% on room air, indicating that myocardial oxygen demand is not being adequately met. In response, the care team initiates supplemental oxygen and considers escalation of therapy with intravenous nitroglycerin and beta-blockers to reduce cardiac workload and improve coronary perfusion.

The emergence of these findings prompts the healthcare team to consider the potential for acute coronary syndrome, requiring further diagnostic imaging such as coronary angiography to assess the extent of coronary artery blockages. The patient's persistent symptoms and diagnostic results highlight the need for timely intervention, possibly including percutaneous coronary intervention (PCI) to restore adequate blood flow and prevent further myocardial damage. The interdisciplinary team must now prioritize stabilizing the patient's condition while coordinating the next steps in his management plan, considering his complex medical history and ongoing risk factors.

Section 2

As the healthcare team continues to monitor the patient, his condition takes a concerning turn. Despite the administration of intravenous nitroglycerin and beta-blockers, the patient's chest discomfort intensifies. His heart rate, initially stable, now rises to 110 beats per minute, suggesting increased sympathetic activity or inadequate pain control. Repeat ECGs reveal worsening ST-segment depression and the emergence of T wave inversions in the anterior leads, indicating a progression of myocardial ischemia. These changes necessitate prompt re-evaluation of his treatment plan.

In response to these developments, the care team conducts a thorough reassessment. The patient's oxygen saturation remains suboptimal at 88% despite supplemental oxygen, prompting the initiation of non-invasive positive pressure ventilation to improve oxygenation and reduce cardiac workload. Additionally, the patient's blood pressure has risen to 170/105 mmHg, further complicating his hemodynamic status. The elevated blood glucose levels persist, now at 260 mg/dL, despite attempts at control, likely exacerbating his endothelial dysfunction and contributing to the unstable coronary plaque.

Due to the patient's deteriorating condition and the risk of an impending myocardial infarction, the decision is made to proceed with urgent coronary angiography. This investigation will provide critical insights into the severity and location of coronary obstructions, guiding the potential need for percutaneous coronary intervention. Throughout this process, the interdisciplinary team remains vigilant, considering the patient's complex medical history, including his poorly controlled diabetes and hyperlipidemia, which necessitates a comprehensive and coordinated approach to his ongoing care.

Section 3

Following the decision to proceed with urgent coronary angiography, the procedure reveals significant stenosis in the left anterior descending artery, with an 85% occlusion, and a moderate 60% stenosis in the right coronary artery. These findings confirm the presence of severe coronary artery disease, contributing to the patient's ongoing ischemic symptoms. Given the critical nature of the left anterior descending artery lesion and its role in supplying a substantial portion of the myocardium, the cardiology team recommends immediate percutaneous coronary intervention (PCI) with stent placement to restore adequate blood flow and mitigate the risk of myocardial infarction.

Post-procedure, the patient's condition initially shows signs of improvement. His chest discomfort subsides significantly, and supplemental oxygen therapy helps increase his oxygen saturation to 94%. However, the patient's heart rate remains elevated at 105 beats per minute, and his blood pressure continues to pose a challenge, now reading 160/100 mmHg. These lingering issues suggest a need for careful adjustment of his antihypertensive and anti-anginal medications to optimize hemodynamic stability. Additionally, his blood glucose remains poorly controlled, with levels fluctuating between 240-250 mg/dL, necessitating further evaluation of his insulin regimen and dietary intake to improve glycemic control.

Despite the successful intervention, the potential for complications such as restenosis or stent thrombosis remains, underscoring the importance of adherence to dual antiplatelet therapy and aggressive risk factor modification. The interdisciplinary team focuses on coordinating follow-up care, emphasizing lifestyle modifications, medication adherence, and regular monitoring to prevent future cardiac events. The patient's complex medical profile, including his diabetes and hyperlipidemia, requires close collaboration with endocrinologists and dietitians to ensure a comprehensive approach to his long-term cardiovascular health. As the patient stabilizes, plans are initiated for his gradual transition to a cardiac rehabilitation program, which will support his recovery and promote sustained lifestyle changes.

Section 4

Change in Patient Status

A few days post-PCI, the patient, Mr. Johnson, experiences a sudden onset of acute shortness of breath and a return of chest pain, albeit less severe than his initial presentation. His heart rate has increased to 120 beats per minute, and his blood pressure has sharply risen to 175/110 mmHg. On auscultation, crackles are noted at the lung bases, suggesting possible fluid overload or early heart failure. The patient reports feeling anxious and fatigued, a change from his previously improving state. An immediate electrocardiogram (ECG) is performed, which does not show new ST-segment changes indicative of myocardial ischemia; however, it does reveal sinus tachycardia.

In response to these developments, the medical team orders a chest X-ray and repeat cardiac biomarkers. The chest X-ray indicates mild pulmonary congestion, confirming suspicions of heart failure exacerbation. Cardiac biomarkers, including troponin levels, remain stable, suggesting no new myocardial injury. This constellation of findings points towards a complication related to hemodynamic stress rather than stent thrombosis. Consequently, diuretics are introduced to manage fluid overload, and adjustments are made to his antihypertensive regimen to address the elevated blood pressure.

The interdisciplinary team revisits Mr. Johnson’s medication adherence and dietary restrictions, emphasizing the critical role of these factors in his overall management. His insulin regimen is also reassessed to improve glycemic control, considering his ongoing hyperglycemia. The patient's gradual integration into a cardiac rehabilitation program becomes more urgent, as it will provide structured support for lifestyle modifications and physical activity, both crucial for preventing further cardiac complications. The team remains vigilant, recognizing that continuous monitoring and timely intervention are essential to Mr. Johnson's recovery and long-term health.

Section 5

Despite the initial interventions, Mr. Johnson's condition does not stabilize as anticipated. He begins to experience increasing dyspnea and a persistent cough, coupled with a sensation of tightness in his chest. His oxygen saturation drops to 89% on room air, prompting the healthcare team to initiate supplemental oxygen therapy to maintain adequate oxygenation. During a focused reassessment, the nurse notes that Mr. Johnson is using accessory muscles to breathe and appears visibly distressed. His vital signs reveal a heart rate of 125 beats per minute, a blood pressure of 170/115 mmHg, and a respiratory rate of 28 breaths per minute. The crackles in his lungs have become more pronounced, extending beyond the bases, and jugular venous distension is observed, indicating worsening heart failure.

In light of these developments, further diagnostic investigations are warranted. An urgent echocardiogram is conducted, revealing a reduced ejection fraction of 35%, suggesting a decline in left ventricular function. This finding correlates with the clinical picture of acute decompensated heart failure. Additionally, a repeat BNP (B-type Natriuretic Peptide) level is significantly elevated at 980 pg/mL, reinforcing the diagnosis of heart failure exacerbation. The team also notes a slight increase in creatinine levels, reaching 1.8 mg/dL, raising concerns about renal perfusion and the potential impact of diuretic therapy.

The clinical reasoning now shifts towards optimizing Mr. Johnson's management by titrating diuretic therapy carefully to reduce fluid overload while monitoring renal function closely. The introduction of a beta-blocker is considered to improve cardiac output and control heart rate, with the aim of stabilizing his cardiovascular status. The healthcare team engages the patient in a discussion about the importance of adherence to medical therapy and lifestyle changes, emphasizing the need for regular follow-up and monitoring. As Mr. Johnson embarks on this next phase of his journey, the collaborative effort between the healthcare team and the patient is crucial to prevent further complications and promote recovery.